J&J’s Ethicon division, world leader in equipment for general surgery, designed a basic prototype of the robot last year and expects it to be a “disruptive” alternative to existing products, Gary Pruden, global chairman of J&J’s medical devices group, said in an interview.
Current robotic systems, including those sold by market leader Intuitive Surgical Inc, are the size of a compact car and require the surgeon to sit at a control panel about 10 feet from the patient, Pruden said
It (JNJ+Google innovation surgical robot) would come loaded with technologies from Alphabet, including “machine learning,” in which the robot could analyze a video library of images from hundreds of previous surgeries in order to instruct the surgeon where to cut.
“Our goal is to have a lower-cost product, with the smallest footprint, with greater capability, that helps to raise the standard of care,” Pruden said. “That would be a market disruption.”
JNJ Financials (Gurufocus.com)
Operating margin (%) 26.5
Net-margin (%) 20.87
ROE (%) 20.61
ROA (%) 11.2
Dividend Yield 3.05
Dividend Payout 56%
Dividend Growth (3y) 7